Cellebrite DI
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +312.3% | -45.8% | -42.9% | +396.0% | +29.5% | +27.8% | |
| – | +44.1% | +20.6% | +29.7% | +8.9% | +6.0% | +11.9% | |
| – | -43.0% | -10.9% | +111.5% | +38.6% | +60.9% | +46.8% | |
| – | -53.6% | -1,325.8% | – | – | – | – | |
| – | +1,738.6% | -58.6% | -113.7% | – | +9.2% | -0.1% | |
| – | -0.5% | +31.2% | +12.0% | -12.8% | +34.0% | +24.7% | |
| – | -86.2% | – | -301.7% | -75.3% | +563.1% | +79.5% | |
| – | -60.0% | +900.0% | -100.0% | – | – | – | |
| – | -89.5% | -100.0% | – | – | – | – | |
| – | -111.4% | +696.0% | – | +55.8% | -5.1% | +43.5% | |
| – | +16.2% | -76.8% | -581.0% | – | -97.9% | -3,237.3% | |
| – | +507.9% | -53.7% | -58.9% | +719.2% | +29.1% | +28.1% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.